GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 93 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2024. The put-call ratio across all filers is 5.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $141,435 | +5.9% | 55,033 | -16.0% | 0.00% | – |
| Q4 2023 | $133,589 | +45.0% | 65,485 | +22.2% | 0.00% | – |
| Q3 2023 | $92,152 | -10.4% | 53,577 | +1.6% | 0.00% | – |
| Q2 2023 | $102,813 | +80.4% | 52,725 | +279.7% | 0.00% | – |
| Q1 2022 | $57,000 | -99.4% | 13,885 | -98.1% | 0.00% | -100.0% |
| Q4 2021 | $9,576,000 | +114.7% | 744,600 | +80.3% | 0.00% | +100.0% |
| Q3 2021 | $4,460,000 | +139.0% | 412,938 | +102.0% | 0.00% | – |
| Q2 2021 | $1,866,000 | – | 204,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |